Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease
Authors
Keywords
Fatty liver, MicroRNAs, Steatosis, Cholesterol, Fibrosis, Histology, Lipoproteins, Lipid metabolism
Journal
PLoS One
Volume 11, Issue 4, Pages e0153497
Publisher
Public Library of Science (PLoS)
Online
2016-04-15
DOI
10.1371/journal.pone.0153497
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease
- (2015) Hiroya Yamada et al. CLINICA CHIMICA ACTA
- Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop
- (2015) Arun J. Sanyal et al. HEPATOLOGY
- Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
- (2015) Erin K. Spengler et al. MAYO CLINIC PROCEEDINGS
- High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease–related fibrosis
- (2015) Fatjon Leti et al. Translational Research
- Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease
- (2014) Duarte M. S. Ferreira et al. FEBS Journal
- Circulating microRNAs as markers of liver inflammation, fibrosis and cancer
- (2014) Christoph Roderburg et al. JOURNAL OF HEPATOLOGY
- Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients
- (2014) Feng Shen WORLD JOURNAL OF GASTROENTEROLOGY
- Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver
- (2013) Hiroya Yamada et al. CLINICA CHIMICA ACTA
- Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma
- (2013) Verena Köberle et al. EUROPEAN JOURNAL OF CANCER
- The role of ultrasound elastographic techniques in chronic liver disease: Current status and future perspectives
- (2013) Fabio Piscaglia et al. EUROPEAN JOURNAL OF RADIOLOGY
- Standardizing Analysis of Circulating MicroRNA: Clinical and Biological Relevance
- (2013) Nicholas H. Farina et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The burden of liver disease in Europe: A review of available epidemiological data
- (2013) Martin Blachier et al. JOURNAL OF HEPATOLOGY
- A population-based study on the prevalence of NASH using scores validated against liver histology
- (2013) Jenni Hyysalo et al. JOURNAL OF HEPATOLOGY
- Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease
- (2013) Shira Zelber-Sagi et al. LIVER INTERNATIONAL
- Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease
- (2013) Hisamitsu Miyaaki et al. LIVER INTERNATIONAL
- MicroRNAs in liver disease
- (2013) Gyongyi Szabo et al. Nature Reviews Gastroenterology & Hepatology
- The genetics of NAFLD
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology and the American Gastroenterological Association
- (2012) Naga Chalasani et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography
- (2012) Robert P. Myers et al. LIVER INTERNATIONAL
- MicroRNAs in metabolism and metabolic disorders
- (2012) Veerle Rottiers et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index
- (2011) S. Petta et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease
- (2011) Silvia Cermelli et al. PLoS One
- Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection
- (2011) Peng Qi et al. PLoS One
- Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease
- (2011) Andrea Tannapfel et al. VIRCHOWS ARCHIV
- Normalization strategies for microRNA profiling experiments: a ‘normal’ way to a hidden layer of complexity?
- (2010) Swanhild U. Meyer et al. BIOTECHNOLOGY LETTERS
- Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes
- (2010) Magali Sasso et al. ULTRASOUND IN MEDICINE AND BIOLOGY
- A novel and universal method for microRNA RT-qPCR data normalization
- (2009) Pieter Mestdagh et al. GENOME BIOLOGY
- Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression
- (2008) Onpan Cheung et al. HEPATOLOGY
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started